{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T19:25:01Z","timestamp":1766690701767,"version":"3.32.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1990,4,1]],"date-time":"1990-04-01T00:00:00Z","timestamp":638928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1990,4]]},"DOI":"10.1007\/bf01648583","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T18:04:59Z","timestamp":1115489099000},"page":"415-420","source":"Crossref","is-referenced-by-count":9,"title":["HIV infection in intravenous drug abusers in Berlin: Risk factors and time trends"],"prefix":"10.1007","volume":"68","author":[{"given":"K.","family":"Stark","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Guggenmoos-Holzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Deininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Bienzle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"unstructured":"Allen DM, Onorato IM, Sweeney P, Jones TS (1989) Seroprevalence of human immunodeficiency virus (HIV) infection among intravenous drug users (IVDUs) in the U.S. Presented at the 5th International Conference on AIDS, Montreal","key":"CR1"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(85)91581-8","volume":"II","author":"G Angarano","year":"1985","unstructured":"Angarano G, Pastore G, Monno L, Santantonio T, Luchena N, Schiraldi O (1985) Rapid spread of HTLV-III among drug addicts in Italy. Lancet II:1302","journal-title":"Lancet"},{"unstructured":"Battjes RJ, Pickens R (1988) HIV infection among intravenous drug abusers in five U.S. cities. Presented at the 4th International Conference on AIDS, Stockholm","key":"CR3"},{"doi-asserted-by":"crossref","unstructured":"Battjes R, Amsel Z, Pickens R, Sholinsky B, Ritz L, Brown L (1989) Heterosexual transmission of HIV among intravenous drug abusers (IVDAs). Presented at the 5th International Conference on AIDS, Montreal","key":"CR4","DOI":"10.1093\/infdis\/162.5.1007"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF01733012","volume":"63","author":"U Bienzle","year":"1985","unstructured":"Bienzle U, Guggenmoos-Holzmann I, Zwingenberger K, Thommsen R, Ritter K, Uy A, Bayer H, Schneider J, Hunsmann G, Coester CH, Kalden JR (1985) Lymphadenopathy and antibodies to HTLV-III in homosexual men. Klin Wochenschr 63:597\u2013602","journal-title":"Klin Wochenschr"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01715858","volume":"65","author":"J Blaser","year":"1987","unstructured":"Blaser J, L\u00fcthy R, Rietiker S, Ledergerber B (1987) Prevalence of HIV antibodies in groups at risk in Z\u00fcrich, Switzerland. Klin Wochenschr 65:245\u2013246","journal-title":"Klin Wochenschr"},{"key":"CR7","first-page":"1009","volume":"I","author":"RP Brettle","year":"1986","unstructured":"Brettle RP, Davidson J, Davidson SJ, Gray JMN, Inglis JM, Conn JS, Bath GE, Gillon J, McClelland DBL (1986) HTLV-III antibodies in an Edinburgh clinic. Lancet I:1009","journal-title":"Lancet"},{"unstructured":"Brown LS Jr, Battjes R, Primm BJ, Foster K, Chu A (1988) Trends in HIV infection among intravenous drug abusers. Presented at the 4th International Conference on AIDS, Stockholm","key":"CR8"},{"key":"CR9","first-page":"833","volume":"36","author":"Centers for Disease Control","year":"1987","unstructured":"Centers for Disease Control (1987) Update: serologic testing for antibody to human immunodeficiency virus. MMWR 36:833\u2013845","journal-title":"MMWR"},{"issue":"Suppl S-4","key":"CR10","first-page":"1","volume":"38","author":"Centers for Disease Control","year":"1988","unstructured":"Centers for Disease Control (1988) AIDS and human immunodeficiency virus infection in the United States: update. MMWR 38 [Suppl S-4]:1\u201338","journal-title":"MMWR"},{"key":"CR11","first-page":"165","volume":"38","author":"Centers for Disease Control","year":"1988","unstructured":"Centers for Disease Control (1988) Update: acquired immunodefiency syndrome associated with intravenous drug use \u2014 United States. MMWR 38:165\u2013170","journal-title":"MMWR"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2105\/AJPH.77.2.169","volume":"77","author":"RE Chaisson","year":"1987","unstructured":"Chaisson RE, Moss AR, Onishi R, Osmond D, Carlson JR (1987) Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Publ Health 77:169\u2013172","journal-title":"Am J Publ Health"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/BF01711856","volume":"62","author":"CH Coester","year":"1984","unstructured":"Coester CH, Bienzle U, Hoffmann HG, Koehn E, Guggenmoos-Holzmann I (1984) Syphilis, hepatitis A and hepatitis B seromarkers in homosexual men. Klin Wochenschr 62:810\u2013813","journal-title":"Klin Wochenschr"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5040\/9798216015680.ch-006","volume-title":"The social dimensions of AIDS. Methods and theory","author":"DC Jarlais Des","year":"1986","unstructured":"Des Jarlais DC, Friedman SR, Strug D (1986) AIDS and needle sharing within the IV drug use subculture. In: Feldman D, Johnson T (eds) The social dimensions of AIDS. Methods and theory. Praeger, New York, pp 111\u2013125"},{"unstructured":"Des Jarlais DC, Friedman SR (1987) AIDS and the sharing of equipment for illicit drug injection: a review of current data. Paper prepared for the National Institute on Drug Abuse","key":"CR15"},{"key":"CR16","first-page":"67","volume":"1","author":"DC Jarlais Des","year":"1987","unstructured":"Des Jarlais DC, Friedman SR (1987) HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS 1:67\u201376","journal-title":"AIDS"},{"key":"CR17","first-page":"283","volume":"87","author":"DC Jarlais Des","year":"1987","unstructured":"Des Jarlais DC, Wish E, Friedman SR, Stoneburner R, Yancovitz SR, Mildvan D, El-Sadr W, Brady E, Cuadrado M (1987) Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. NY State J Med 87:283\u2013286","journal-title":"NY State J Med"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0140-6736(85)90113-8","volume":"II","author":"P Ferroni","year":"1985","unstructured":"Ferroni P, Geroldi D, Galli C, Zanetti AR, Cargnel A (1985) HTLV-III antibody among Italian drug addicts. Lancet II:52\u201353","journal-title":"Lancet"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(86)92405-0","volume":"I","author":"EAC Follet","year":"1986","unstructured":"Follet EAC, McIntyre A, O'Donnell B, Clements GB, Desselberger U (1986) HTLV-III antibody in drug abusers in the West of Scotland: the Edinburgh connection. Lancet I:446\u2013447","journal-title":"Lancet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(85)92277-9","volume":"I","author":"D Fuchs","year":"1985","unstructured":"Fuchs D, Blecha HG, Deinhardt F, Dierich MP, Goebel FD, Hengster P, Hinterhuber H, Schoenitzer D, Traill K, Wachter H (1985) High frequency of HTLV-III antibodies among heterosexual IV drug abusers in the Austrian Tyrol. Lancet I:1506","journal-title":"Lancet"},{"key":"CR21","first-page":"65","volume":"1","author":"D Fuchs","year":"1988","unstructured":"Fuchs D, Unterweger B, Hansen A, Reibnegger G, Werner ER, Hengster P, Hinterhuber H, Dierich MP, Wachter H, Blattner WA, Weiss SH (1988) Anti-HIV-1 antibodies, anti-HTLV-I antibodies and neopterin levels in parenteral drug addicts in the Austrian Tyrol. J Acquired Immune Deficiency Syndromes 1:65\u201366","journal-title":"J Acquired Immune Deficiency Syndromes"},{"unstructured":"Fuchs D, Unterweger B, Hinterhuber H, Dierich MP, Weiss SH, Wachter H (1988) Successful preventive measures in a community of IV drug addicts. Presented at the 4th International Conference on AIDS, Stockholm","key":"CR22"},{"key":"CR23","first-page":"347","volume":"29","author":"H Gro\\e-Aldenh\u00f6vel","year":"1986","unstructured":"Gro\\e-Aldenh\u00f6vel H, Brcanovic P, Schumann V, Koch MA (1986) Anamnestische und HIV-serologische Befunde bei Personen mit intraven\u00f6sem Drogenmi\\brauch. Bundesgesundhbl 29:347\u2013349","journal-title":"Bundesgesundhbl"},{"doi-asserted-by":"crossref","unstructured":"Guggenmoos-Holzmann I, Deininger S, Laukamm-Josten U, Bienzle U (1990) Time trends of HIV-I antibody prevalence in homosexual men. Int J Med Microbiol (in press)","key":"CR24","DOI":"10.1016\/S0934-8840(11)80037-X"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF01745578","volume":"65","author":"G Harms","year":"1987","unstructured":"Harms G, Laukamm-Josten U, Bienzle U, Guggenmoos-Holzmann I (1987) Risk factors for HIV infection in German i.v. drug abusers. Klin Wochenschr 65:376\u2013379","journal-title":"Klin Wochenschr"},{"key":"CR26","volume-title":"Epidemiologic research","author":"D Kleinbaum","year":"1982","unstructured":"Kleinbaum D, Kupper L, Morgenstern H (1982) Epidemiologic research. Lifetime Learning Publications, California"},{"key":"CR27","first-page":"328","volume":"11","author":"H K\u00f6hler","year":"1985","unstructured":"K\u00f6hler H, Lange W, Vettermann W, Pauli G, Koch MA (1985) Untersuchung auf LAV\/HTLV-III Antik\u00f6rper bei Insassen Berliner Haftanstalten mit Hepatitis Risiko. Bundesgesundhbl 11:328\u2013329","journal-title":"Bundesgesundhbl"},{"unstructured":"Lange WR, Primm BJ, Tennant FS, Payte JT, Luney CM, Jaffe JH (1987) The geographic distribution of HIV antibodies in parenteral drug abusers. Presented at the 3rd International Conference on AIDS, Washington DC","key":"CR28"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF01667214","volume":"13","author":"A Lazzarin","year":"1985","unstructured":"Lazzarin A, Galli M, Geroldi D, Zanetti A, Crocchiolo P, Aiuti F, Moroni M (1985) Epidemic of LAV\/HTLV-III infection in drug addicts in Milan: serological survey and clinical follow-up. Infection 13:216\u2013218","journal-title":"Infection"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(85)92771-0","volume":"II","author":"PP Mortimer","year":"1985","unstructured":"Mortimer PP, Vandervelde EM, Jesson WJ, Pereira MS, Burkhardt F (1985) HTLV-III antibody in Swiss and English intravenous drug abusers. Lancet II:449\u2013450","journal-title":"Lancet"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0140-6736(85)90136-9","volume":"II","author":"PP Mortimer","year":"1985","unstructured":"Mortimer PP, Parry JV, Mortimer JY (1985) Which anti-HTLV III\/LAV assays for screening and confirmatory testing? Lancet II:873\u2013877","journal-title":"Lancet"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF01785522","volume":"65","author":"G Paschelke","year":"1987","unstructured":"Paschelke G, Altvater-Kremer G, Meyer WD, Kremer H (1987) HTLV-III antibody prevalence among young delinquent drug abusers in long-term residential treatment at a North-German drug clinic. Klin Wochenschr 65:22\u201326","journal-title":"Klin Wochenschr"},{"unstructured":"Pehrson PO, Gaines H, Gyllensten K, Moberg LG, Struve J, S\u00f6nnerborg A, Akerlund B (1988) Serological markers for HAV, HBV, lues and toxoplasmosis in HIV seropositive drug abusers. Presented at the 4th International Conference on AIDS, Stockholm","key":"CR33"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(85)90721-4","volume":"I","author":"JF Peutherer","year":"1985","unstructured":"Peutherer JF, Edmond E, Simmonds P, Dickson JD, Bath GE (1985) HTLV-III antibodies in Edinburgh drug addicts. Lancet I:1129\u20131130","journal-title":"Lancet"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/bmj.292.6519.527","volume":"292","author":"JR Robertson","year":"1986","unstructured":"Robertson JR, Bucknall ABV, Welsby PD, Roberts JJK, Inglis JM, Peutherer JF, Brettle RP (1986) Epidemic of AIDS-related virus (HTLV-III\/LAV) infection among intravenous drug users. Br Med J 292:527\u2013529","journal-title":"Br Med J"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(85)90260-0","volume":"II","author":"JM Rodrigo","year":"1985","unstructured":"Rodrigo JM, Serra MA, Aguilar E, Del Olmo JA, Gimeno V, Aparisi L (1985) HTLV-III antibodies in drug addicts in Spain. Lancet II:156\u2013157","journal-title":"Lancet"},{"unstructured":"Roumeliotou A, Nestoridou A, Kotsianopoulou M, Sapounas Th, Papaevangolou G (1988) Epidemiology of HIV infection in Greek IV drug addicts. Presented at the 4th International Conference on AIDS, Stockholm","key":"CR37"},{"unstructured":"Schoenbaum EE, Selwyn PA, Hartel D, Klein RS, Davenny K, Friedland GH (1987) HIV seroconversion in intravenous drug abusers: rate and risk factors. Presented at the 3rd International Conference on AIDS, Washington DC","key":"CR38"},{"doi-asserted-by":"crossref","unstructured":"Titti F, Rezza G, Verani P, Butto S, Rapicetta M, Oliva C, Sernicola L, Rossi GB (1988) HIV-I, HTLV-I, HBV infections and risk factors analysis among intravenous drug abusers. Presented at the 4th International Conference on AIDS, Stockholm","key":"CR39","DOI":"10.1016\/S0140-6736(88)91521-8"},{"unstructured":"Van den Hoek JAR, Coutinho RA, Zadelhoff AW, Van Haastrecht HJA, Goudsmit J (1987) Prevalence, incidence and risk factors of HIV-infection among drug addicts in Amsterdam. Presented at the 3rd International Conference on AIDS, Washington DC","key":"CR40"},{"unstructured":"Van Haastrecht HJA, Van den Hoek JAR, Coutinho RA (1989) No trend in yearly HIV-seroprevalence rates among IVDA in Amsterdam: 1986\u20131988. Presented at the 5th International Conference on AIDS, Montreal","key":"CR41"},{"unstructured":"Weiss SH, Ginzburg HM, Goedert JJ (1985) Risk for HTLV-III exposure and AIDS among parenteral drug abusers in New Jersey. Presented at the International Conference on AIDS, Atlanta","key":"CR42"},{"key":"CR43","first-page":"1","volume":"21","author":"WHO Collaborating Centre on AIDS","year":"1989","unstructured":"WHO Collaborating Centre on AIDS (1989) AIDS Surveillance in Europe. Quarterly Report 21:1\u201318","journal-title":"Quarterly Report"},{"key":"CR44","first-page":"567","volume":"15","author":"G Zoulek","year":"1986","unstructured":"Zoulek G, G\u00fcrtler L, Eberle J, Lorbeer B, Deinhardt F (1986) Zunahme der Pr\u00e4valenz von Antik\u00f6rpern gegen LAV\/HTLV-III bei Drogenabh\u00e4ngigen in der Bundesrepublik Deutschland. Dtsch Med Wochenschr 15:567\u2013570","journal-title":"Dtsch Med Wochenschr"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01648583.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01648583\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01648583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T04:31:39Z","timestamp":1735705899000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01648583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,4]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1990,4]]}},"alternative-id":["BF01648583"],"URL":"https:\/\/doi.org\/10.1007\/bf01648583","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"type":"print","value":"0023-2173"},{"type":"electronic","value":"1432-1440"}],"subject":[],"published":{"date-parts":[[1990,4]]}}}